Examination Report |
1 | Additional Representation Sheet | 26 Jun 2015 |
1 | TM-1 | 26 Jun 2015 |
2 | Additional Representation Sheet | 26 Jun 2015 |
2 | Authorization Document (POA) | 26 Jun 2015 |
3 | Authorization Document (POA) | 26 Jun 2015 |
3 | TM-1 | 26 Jun 2015 |
4 | Reply to Exam Report (MIS-R) | 03 Oct 2016 |
5 | Journal Copy | 24 May 2019 |
6 | Certificate | 26 Jul 2019 |
7 | TM-R(RENEWAL OF TRADE MARK) | 02 Jul 2024 |
1 | Hearing Notice (Show Cause) | 6386105 | 2920542 | 21 May 2018 |
2 | Tribunal Accepted Notice for : 2994039 | 7883583 | 3936171 | 01 Mar 2019 |
3 | RENEWAL INTIMATION LETTER | 18454163 | 05 Jul 2024 |
The application for Amvoxin was made on 26 June 2015.
The trademark applicant for Amvoxin is BLISS GVS PHARMA.
Amvoxin is applied in class(es) 5.
Application for Amvoxin is on Registered stage.
Application Id allotted to Amvoxin is 2994039.
Trademark agent or attorney for the application is H. P. Associates.
Amvoxin filed with the Intellectual property office as a DEVICE.